JPS6461421A - Composition based on phosphatidyl choline and medicinal use - Google Patents
Composition based on phosphatidyl choline and medicinal useInfo
- Publication number
- JPS6461421A JPS6461421A JP63166650A JP16665088A JPS6461421A JP S6461421 A JPS6461421 A JP S6461421A JP 63166650 A JP63166650 A JP 63166650A JP 16665088 A JP16665088 A JP 16665088A JP S6461421 A JPS6461421 A JP S6461421A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- phosphatidyl choline
- salt solution
- unsaturated fatty
- dispersing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 title abstract 3
- 239000012266 salt solution Substances 0.000 abstract 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 210000004379 membrane Anatomy 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 235000019486 Sunflower oil Nutrition 0.000 abstract 1
- 239000010775 animal oil Substances 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 210000003989 endothelium vascular Anatomy 0.000 abstract 1
- 210000001156 gastric mucosa Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000004347 intestinal mucosa Anatomy 0.000 abstract 1
- 210000004303 peritoneum Anatomy 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 239000003549 soybean oil Substances 0.000 abstract 1
- 235000012424 soybean oil Nutrition 0.000 abstract 1
- 239000002600 sunflower oil Substances 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8702784A SE457933B (sv) | 1987-07-06 | 1987-07-06 | Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6461421A true JPS6461421A (en) | 1989-03-08 |
Family
ID=20369073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63166650A Pending JPS6461421A (en) | 1987-07-06 | 1988-07-04 | Composition based on phosphatidyl choline and medicinal use |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0299937A1 (enExample) |
| JP (1) | JPS6461421A (enExample) |
| SE (1) | SE457933B (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003506397A (ja) * | 1999-08-06 | 2003-02-18 | マックス−デルブルック−セントルム フュア モレキュラー メディツィン | 埋め込み可能な有効成分デポ剤 |
| JP2005047929A (ja) * | 1998-05-13 | 2005-02-24 | Ml Lab Plc | 外科手術上の癒着を阻止するためのデキストリンを含有する組成物 |
| WO2008084864A1 (ja) * | 2007-01-11 | 2008-07-17 | Nisshin Pharma Inc. | カプサイシン受容体活性化剤及びそれを噴霧する装置 |
| JP2013542917A (ja) * | 2010-08-13 | 2013-11-28 | コンパニ・ジェルベ・ダノン | 胃上部領域のための製品 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4005711C1 (enExample) * | 1990-02-23 | 1991-06-13 | A. Nattermann & Cie Gmbh, 5000 Koeln, De | |
| FR2670365B1 (fr) * | 1990-12-18 | 1993-12-24 | Eurial | Boisson lactee et procede pour sa preparation. |
| FR2714621B1 (fr) * | 1994-01-06 | 1996-02-23 | Centre Nat Rech Scient | Procédé de préparation de liposomes sans utilisation de solvant organique. |
| JPH11513393A (ja) * | 1995-10-12 | 1999-11-16 | ジーエス ディベロップメント エービー | 皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物 |
| GB0200704D0 (en) * | 2002-01-14 | 2002-02-27 | Britannia Pharmaceuticals Ltd | Use of phospholipids in peritoneal dialysis |
| WO2004024123A1 (en) * | 2002-09-16 | 2004-03-25 | Vasogen Ireland Limited | Accelerating recovery from trauma |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55153713A (en) * | 1979-05-02 | 1980-11-29 | Kureha Chem Ind Co Ltd | Pharmaceutical preparation of ribosome containing active substance |
| DE3028074C2 (de) * | 1980-07-22 | 1983-12-08 | Kurt Kampffmeyer Mühlenvereinigung KG, 2000 Hamburg | Verfahren zur Herstellung eines lecithinhaltigen Produktes |
| DE3470277D1 (en) * | 1984-01-11 | 1988-05-11 | Von Mletzko Armin | Dietetic composition |
| IT1176916B (it) * | 1984-10-10 | 1987-08-18 | Elvira Pistolesi | Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica |
-
1987
- 1987-07-06 SE SE8702784A patent/SE457933B/sv not_active IP Right Cessation
-
1988
- 1988-06-21 EP EP88850222A patent/EP0299937A1/en not_active Withdrawn
- 1988-07-04 JP JP63166650A patent/JPS6461421A/ja active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005047929A (ja) * | 1998-05-13 | 2005-02-24 | Ml Lab Plc | 外科手術上の癒着を阻止するためのデキストリンを含有する組成物 |
| JP2003506397A (ja) * | 1999-08-06 | 2003-02-18 | マックス−デルブルック−セントルム フュア モレキュラー メディツィン | 埋め込み可能な有効成分デポ剤 |
| WO2008084864A1 (ja) * | 2007-01-11 | 2008-07-17 | Nisshin Pharma Inc. | カプサイシン受容体活性化剤及びそれを噴霧する装置 |
| JP2013542917A (ja) * | 2010-08-13 | 2013-11-28 | コンパニ・ジェルベ・ダノン | 胃上部領域のための製品 |
Also Published As
| Publication number | Publication date |
|---|---|
| SE8702784D0 (sv) | 1987-07-06 |
| SE457933B (sv) | 1989-02-13 |
| EP0299937A1 (en) | 1989-01-18 |
| SE8702784L (enExample) | 1989-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12076333B2 (en) | Lysophosphatidylcholine compositions | |
| JPS6461421A (en) | Composition based on phosphatidyl choline and medicinal use | |
| GB2084172A (en) | Lipid compositions useful in dietetics | |
| EP0180786A1 (en) | Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity | |
| UA76108C2 (en) | Use of therapeutic combination of fatty acids | |
| EP0312612A4 (en) | Nutritive emulsion preparation | |
| KR930012039A (ko) | 초음파 화상형성용 콘트라스트제 | |
| DE3685392D1 (de) | Galenische formen mit verzoegerter verapamil-freisetzung, deren herstellung und diese enthaltende arzneimittel. | |
| DK68080A (da) | Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod | |
| JPS6413021A (en) | Lithium salt-containing pharmacological composition | |
| DE69512929T2 (de) | Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen | |
| HUP0101248A2 (hu) | Gyomor- és/vagy nyombél-adhezív gyógyászati készítmények | |
| Krawitt et al. | The role of intestinal transport proteins in cortisone-mediated suppression of Ca2+ absorption | |
| Bloom et al. | Absorption of phospholipides: manner of transport from intestinal lumen to lacteals | |
| ATE227304T1 (de) | Tetraetherlipide und diese enthaltende liposomen sowie deren verwendung | |
| PT682879E (pt) | Produto alimentar dietetico com acidos gordos de cadeia media e sua utilizacao | |
| EP1119360B1 (en) | Compositions for increasing intestinal absorption of fats | |
| NO20002045D0 (no) | Fremgangsmõte for øking av konsentrasjonen av konjugert linolsyre i melk og/eller vevfett av en drøvtygger | |
| JPS6440540A (en) | Magnesium hydroxide for polymer additive | |
| DE2640707A1 (de) | Gewinnung von im darm resorbierbaren protein- und peptidloesungen | |
| DE69731981T2 (de) | Neue verbesserte formulierung zur behandlung von thromboembolismus | |
| JPS6439939A (en) | Fat-containing composition and production thereof | |
| JP2941787B2 (ja) | 多価不飽和脂肪酸を含有する医薬組成物および健康食品 | |
| JPS57128624A (en) | Preventive and remedy for disease caused by srs-a | |
| EP0714240A1 (en) | Reduced absorption of fatty acids |